Stroke After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction Timing, Characteristics, and Clinical Outcomes

被引:45
作者
Guptill, Jeffrey T. [1 ]
Mehta, Rajendra H. [1 ]
Armstrong, Paul W. [2 ]
Horton, John [1 ]
Laskowitz, Daniel [1 ]
James, Stefan [3 ]
Granger, Christopher B. [1 ]
Lopes, Renato D. [1 ]
机构
[1] Duke Clin Res Inst, Durham, NC 27705 USA
[2] Univ Alberta, Edmonton, AB, Canada
[3] Uppsala Clin Res Ctr, Uppsala, Sweden
关键词
myocardial infarction; myocardial reperfusion; outcomes; primary percutaneous coronary intervention; stroke; PLATELET GLYCOPROTEIN IIB/IIIA; GLOBAL REGISTRY; APEX-AMI; TRIAL; PEXELIZUMAB; MORTALITY; THERAPY; EVENTS; RISK;
D O I
10.1161/CIRCINTERVENTIONS.112.000159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Stroke is a rare but potentially devastating complication of acute myocardial infarction. Little is known about stroke timing, characteristics, and clinical outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PCI). Methods and Results-We studied 5372 patients enrolled in the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. We analyzed stroke incidence, type, timing, and association with the prespecified 90-day clinical outcomes. Cox proportional hazards modeling was performed to assess the relationship between stroke and outcomes, after adjusting baseline characteristics and analyzing stroke as a time-dependent covariate. Stroke occurred in 69 primary patients with PCI (1.3%). A third of strokes were ischemic (n=23; 33%), 12% (n=8) were hemorrhagic, and the remaining 55% (n=38) were of uncertain type. The median (25th, 75th percentile) time of stroke occurrence was 6 (3, 14) days. Overall, 43% of strokes occurred within 48 hours of PCI, and all hemorrhagic strokes occurred within 48 hours. Stroke was associated with an increased risk of 90-day death (unadjusted hazard ratio [HR], 8.0; 95% confidence interval [CI], 4.8-13.5), congestive heart failure (unadjusted HR, 3.2; 95% CI, 1.3-7.8), and 30-day hospital readmission (unadjusted HR, 3.2; 95% CI, 2.0-5.1). After adjustment, stroke was still strongly associated with 90-day death (adjusted HR, 5.6; 95% CI, 3.2-9.8) and the combination end point of death, congestive heart failure, or cardiogenic shock at 90 days (adjusted HR, 2.4; 95% CI, 1.2-4.7). Conclusions-Stroke is an infrequent complication in the setting of ST-segment elevation myocardial infarction treated with primary PCI but is associated with increased morbidity and mortality. Studies to determine mechanisms that may be responsible for strokes that occur >48 hours from primary PCI are warranted.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 20 条
[1]   Incidence and Predictors of Stroke Associated With Percutaneous Coronary Intervention [J].
Aggarwal, Atul ;
Dai, David ;
Rumsfeld, John S. ;
Klein, Lloyd W. ;
Roe, Matthew T. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (03) :349-353
[2]  
Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43
[3]   Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention [J].
Armstrong, PW ;
Adams, PX ;
Al-Khalidi, HR ;
Hamm, C ;
Holmes, D ;
O'Neill, W ;
Todaro, TG ;
Vahanian, A ;
Van de Werf, F ;
Granger, CB .
AMERICAN HEART JOURNAL, 2005, 149 (03) :402-407
[4]   Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes - Findings from a global registry of acute coronary events [J].
Budaj, A ;
Flasinska, K ;
Gore, JM ;
Anderson, FA ;
Dabbous, OH ;
Spencer, FA ;
Goldberg, RJ ;
Fox, KAA .
CIRCULATION, 2005, 111 (24) :3242-3247
[5]   Stroke in relation to cardiac procedures in patients with non-ST-elevation acute coronary syndrome -: A study involving >18 000 patients [J].
Cronin, L ;
Mehta, SR ;
Zhao, F ;
Pogue, J ;
Budaj, A ;
Hunt, D ;
Yusuf, S .
CIRCULATION, 2001, 104 (03) :269-274
[6]  
Demaerschalk BM, 2010, AM J MANAG CARE, V16, P525
[7]   Characteristics of cerebrovascular accidents after percutaneous coronary interventions [J].
Dukkipati, S ;
O'Neill, WW ;
Harjai, KJ ;
Sanders, WP ;
Deo, D ;
Boura, JA ;
Bartholomew, BA ;
Yerkey, MW ;
Sadeghi, HM ;
Kahn, JK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) :1161-1167
[8]   Stroke complicating percutaneous coronary interventions - Incidence, predictors, and prognostic implications [J].
Fuchs, S ;
Stabile, E ;
Kinnaird, TD ;
Mintz, GS ;
Gruberg, L ;
Carlos, DA ;
Pinnow, EE ;
Kornowski, R ;
Suddath, WO ;
Satler, LF ;
Pichard, AD ;
Kent, KM ;
Weissman, NJ .
CIRCULATION, 2002, 106 (01) :86-91
[9]   STROKE AFTER THROMBOLYSIS - MORTALITY AND FUNCTIONAL OUTCOMES IN THE GUSTO-I TRIAL [J].
GORE, JM ;
GRANGER, CB ;
SIMOONS, ML ;
SLOAN, MA ;
WEAVER, D ;
WHITE, HD ;
BARBASH, GI ;
VANDEWERF, F ;
AYLWARD, PE ;
TOPOL, EJ ;
CALIFF, RM .
CIRCULATION, 1995, 92 (10) :2811-2818
[10]   Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intenventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age [J].
Iakovou, I ;
Dangas, G ;
Mehran, R ;
Mintz, GS ;
Lansky, AJ ;
Aymong, ED ;
Nikolsky, E ;
Vagaonescu, T ;
Glasser, LA ;
Stone, GW ;
Leon, MB ;
Moses, JW .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (09) :1083-1086